Takuya Fukazawa

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Etsuko Yokota, Miki Iwai, Yuta Ishida, Takuro Yukawa, Masaki Matsubara, Yoshio Naomoto, Hideyo Fujiwara, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo. Human cell 37 (4) (2024)
Etsuko Yokota, Miki Iwai, Yuta Ishida, Takuro Yukawa, Masaki Matsubara, Yoshio Naomoto, Hideyo Fujiwara, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo. Human cell 37 (4) (2024)
Miki Iwai, Etsuko Yokota, Yuta Ishida, Takuro Yukawa, Yoshio Naomoto, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma. Human cell (2024)
Etsuko Yokota, Miki Iwai, Yuta Ishida, Takuro Yukawa, Masaki Matsubara, Yoshio Naomoto, Hideyo Fujiwara, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo. Human cell (2024)
Miki Iwai, Etsuko Yokota, Yuta Ishida, Takuro Yukawa, Yoshio Naomoto, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma. Human cell 37 (4) (2024)
Miki Iwai, Etsuko Yokota, Yuta Ishida, Takuro Yukawa, Yoshio Naomoto, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma. Human cell 37 (4) (2024)
Etsuko Yokota, Miki Iwai, Yuta Ishida, Takuro Yukawa, Masaki Matsubara, Yoshio Naomoto, Hideyo Fujiwara, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo. Human cell 37 (4) (2024)
Miki Iwai, Etsuko Yokota, Yuta Ishida, Takuro Yukawa, Yoshio Naomoto, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma. Human cell 37 (4) (2024)
Etsuko Yokota, Miki Iwai, Yuta Ishida, Takuro Yukawa, Masaki Matsubara, Yoshio Naomoto, Hideyo Fujiwara, Yasumasa Monobe, Minoru Haisa, Nagio Takigawa, Takuya Fukazawa, Tomoki Yamatsuji
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo. Human cell 37 (4) (2024)
Koichi Tomoshige, William D Stuart, Iris M Fink-Baldauf, Masaoki Ito, Tomoshi Tsuchiya, Takeshi Nagayasu, Tomoki Yamatsuji, Morihito Okada, Takuya Fukazawa, Minzhe Guo, Yutaka Maeda
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung. Cancer research (2023)
Yuta Ishida, Takuro Yukawa, Yasunari Nagasaki, Daisuke Minami, Hiroyasu Fujiwara, Yasumasa Monobe, Takuya Fukazawa, Tomoki Yamatsuji
A surgical case of pulmonary adenocarcinoma in the right upper lobe associated with a systemic artery-to-pulmonary artery fistula. Thoracic cancer (2023)
Takuro Yukawa, Yuta Ishida, Yoshio Naomoto, Yasumasa Monobe, Takuya Fukazawa, Tomoki Yamatsuji
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report. Thoracic cancer 13 (8) (2022)
Etsuko Yokota, Miki Iwai, Takuro Yukawa, Masakazu Yoshida, Yoshio Naomoto, Minoru Haisa, Yasumasa Monobe, Nagio Takigawa, Minzhe Guo, Yutaka Maeda, Takuya Fukazawa, Tomoki Yamatsuji
Clinical application of a lung cancer organoid (tumoroid) culture system. NPJ precision oncology 5 (1) (2021)
Koichi Tomoshige, Minzhe Guo, Tomoshi Tsuchiya, Takuya Fukazawa, Iris M Fink-Baldauf, William D Stuart, Yoshio Naomoto, Takeshi Nagayasu, Yutaka Maeda
An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo. Oncogene 37 (28) (2018)

Takuya Fukazawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takuya Fukazawa